Modified low density lipoprotein and cytokines mediate monocyte adhesion to smooth muscle cells

Atherosclerosis

Volumn 127, Issue 2, 1996, Pages 167-176

  Thorne, S A ^a,b   Abbot, S E ^a   Stevens, C R ^a   Winyard, P G ^a   Mills, P G ^a   Blake, D R ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

coronary smooth muscle cells; low density lipoprotein; monocyte adhesion

Indexed keywords

CYTOKINE; INTERLEUKIN 1; LOW DENSITY LIPOPROTEIN; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CELL CULTURE; CORONARY ARTERY; ELECTROPHORESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MONOCYTE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANTIBODIES, MONOCLONAL; CELL ADHESION; CELLS, CULTURED; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; LEUKOCYTE COUNT; LIPOPROTEINS, LDL; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; OXIDATION-REDUCTION; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030596070     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05948-5     Document Type: Article

References (47)

1. [1] Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
2. [2] Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995-8.
3. [3] Giraldo AA, Esposo OM, Meis JM. Intimal hyperplasia as a cause of restenosis after percutaneous transluminal coronary angioplasty. Arch Pathol Lab Med 1985;109:173-5.
4. [4] Poston RM, Haskard DO, Coucher HR, Gall NP, Johnson-Tiedy RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992;140:665-73.
5. [5] O'Brien KD, Allen MD, McDonald TO et al. Vascular cell adhesion molecule 1 is expressed in human coronary atherosclerotic plaques. J Clin Invest 1993;92;945-51.
6. [6] Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990;4:2868-80.
7. [7] Stemme S, Patarroyo M, Hansson GK. Adhesion of activated T lymphocytes to vascular smooth muscle cells and dermal fibroblasts is mediated by beta 1-and beta 2-integrins. Scand J Immunol 1992;36(2):233-42.
8. [8] Gamble JR, Bradley S, Noack L, Vadas MA. TGF-β and endothelial cells inhibit VCAM-1 expression on vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1995;15:949-55.
9. [9] Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984;4:357-64.
10. [10] Hiramatsu K, Rosen H, Heinecke JW, Wolfbauer G, Chait A. Superoxides initiate oxidation of low density lipoprotein by monocytes. Arteriosclerosis 1987;7:55-60.
11. [11] Frostegård J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, Gidlund M. Oxidised low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 1990;87:904-8.
12. [12] Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260-6.
13. [13] Smirnov VN, Orekhov AN. Smooth muscle cells from adult human aorta. In: Piper HM, (ed). Cell Culture Techniques in Heart and Vessel Research. Springer-Verlag 1990;271-89.
14. [14] Thorne SA, Abbot SE, Winyard PG, Blake DR, Mills PG. The extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells. Heart 1995;75:11-16.
15. [15] Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973;52:2745-6.
16. [16] Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
17. [17] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, Protein measurement with the Folin Phenol reagent. J Biol Chem 1951;193:265.
18. [18] Yin ET, Galanos C, Kinsky S et al. Picogram-sensitivity assay for endotoxin: gelation of limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from gram-negative bacteria. Biochim Biophys Acta 1972;261:284-9.
19. [19] Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegel G, Jürgens G. Biochemical, structural and functional properties of oxidised low-density lipoprotein. Chem Res Toxicol 1990;3:77-92.
20. [20] Yagi K. Assay for serum lipid peroxide level and its clinical significance. In: Lipid Peroxides in Biology and Medicine. New York: Academic Press 1982. 223-42.
21. [21] Esterbauer H, Dieber-Rotheneder M, Waeg G, Puhl H, Tatzber F. Endogenous antioxidants and lipid peroxidation. Biochem Soc Trans 1990; 18:1059-61.
22. [22] Böyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 1976;5(suppl 5):9-15.
23. [23] Wellicome SM, Thornhill MH, Pitzalis C et al. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumour necrosis factor, IL-1, or lipopolysaccharide, J Immunol 1990;144:2558-65.
24. [24] Couffinhal T, Duplàa C, Labat L et al. Tumor necrosis factor-a stimulates ICAM-1 expression in human vascular smooth muscle cells. Arterioscler Thromb 1993;13:407-14.
25. [25] Li H, Cybulsky MI, Gimbrone MA, Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol 1993; 143(6): 1551-9.
26. [26] Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JSS, Kyan-Uang U, Haskard DO. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. J Immunol 1991;146(2):592-8.
27. [27] Stemme S, Patarroyo M, Hansson GK. Adhesion of activated T lymphocytes to vascular smooth muscle cells and dermal fibroblasts is mediated by beta 1-and beta 2-integrins. Scand J lmmunol 1992;36(2):233-42.
28. [28] Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1, homologous to ICAM-1. Nature 1989;339:61-4.
29. [29] Maylor CW, Webb DL, Bombara MP, Greve JM, Blue ML. Expression of vascular adhesion molecule-1 in fibroblastlike synoviocytes after stimulation with tumor necrosis factor. Am J Pathol 1992;140(5):1055-60.
30. [30] Swerlick RA, Lee KH, Li LJ, Sepp NY, Caughman SW, Lawley TJ. Regulation of vascular cell adhesion molecule-1 on human dermal microvascular endothelial cells. J Immunol 1992;149:698-705.
31. [31] Williams KJ, Tabas I. The response to retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15(5):551-61.
32. [32] Autio I, Jaakkola O, Solakivi T, Nikkari T. Oxidised low density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS 1990;277(1,2):247-9.
33. [33] Frostegård J, Haegerstrand A, Gidlund M, Nilsson J. Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 1991;90:119-26.
34. [34] Butcher EC, Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-6.
35. [35] Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 1993;92:471-8.
36. [36] Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterisation of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992;267:16323-9.
37. [37] Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W. Tumor necrosis factor α (TNFα)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 1993;177:1277-86.
38. [38] Montgomery KF, Osborn L, Hession C, Tizard R, Goff D, Vassallo C, Tarr PI, Bomsztyk K, Lobb R, Harlan JM. Activation of endothelial-leukocyte adhesion molecule-1 (ELAM-1) gene transcription. Proc Natl Acad Sci USA 1991;88:6523-7.
39. [39] Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemotactic protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2423-8.
40. [40] Navab M, Imes SS, Hama SY et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991;88:2039-46.
41. [41] Gushing SD, Berliner JA, Valente JA et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134-8.
42. [42] Kim JA, Territo MC, Wayner E et al. Partial characterisation of leukocyte binding molecules on endothelial cells induced by minimally oxidised LDL. Arterioscler Thromb 1994;14:427-33.
43. [43] Schwartz D, Andalibi A, Chaverri-Almada L et al. Role of the GRO family of chemokines in monocyte adhesion to mm-LDL stimulated endothelium. J Clin Invest 1994;94:1968-73.
44. [44] Calderon TM, Factor SM, Hatcher VB, Berliner JA, Berman JW. An endothelial cell adhesion protein for monocytes recognised by monoclonal antibody IG9. Lab Invest 1994;70(6):836-49.
45. [45] Weber C, Erl W, Weber PC. Enhancement of monocyte adhesion to endothelial cells by oxidatively modified LDL is mediated by activation of CD11b. Biochem Biophs Res Commun 1995;206(2):621-8.
46. [46] Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979;76:333-7.
47. [47] Richardson P, Davies M, Born G. Influence of plaque configuration and stress distribution and fissuring on coronary atherosclerotic plaques. Lancet 1989;ii:941-4.